Chemoinformaics analysis of 6-BENZYL-2-AMINO-1H-PURINE
| Molecular Weight | 225.255 | nRot | 2 |
| Heavy Atom Molecular Weight | 214.167 | nRig | 17 |
| Exact Molecular Weight | 225.101 | nRing | 3 |
| Solubility: LogS | -2.77 | nHRing | 2 |
| Solubility: LogP | 0.389 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 15 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 16 |
| nHA | 4 | APOL | 32.8747 |
| nHD | 2 | BPOL | 14.4553 |
| QED | 0.615 |
| Synth | 2.875 |
| Natural Product Likeliness | -0.108 |
| NR-PPAR-gamma | 0.027 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.027 |
| HIA | 0.014 |
| CACO-2 | -5.192 |
| MDCK | 0.00000716 |
| BBB | 0.189 |
| PPB | 0.721545 |
| VDSS | 1.421 |
| FU | 0.339584 |
| CYP1A2-inh | 0.094 |
| CYP1A2-sub | 0.67 |
| CYP2c19-inh | 0.27 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.012 |
| CYP2d6-inh | 0.158 |
| CYP2d6-sub | 0.056 |
| CYP3a4-inh | 0.492 |
| CYP3a4-sub | 0.494 |
| CL | 9.702 |
| T12 | 0.898 |
| hERG | 0.087 |
| Ames | 0.061 |
| ROA | 0.985 |
| SkinSen | 0.891 |
| Carcinogencity | 0.068 |
| EI | 0.331 |
| Respiratory | 0.979 |
| NR-Aromatase | 0.877 |
| Antiviral | No |
| Prediction | 0.630719 |